Concepedia

W. Zou

WZ

Statistics

Publications

2

Citations

31

H-Index

2

Active since

2022

Affiliations

Northwest Behavioral Medicine(Current)

Roche (United Kingdom)

Stanford University

Ospedale San Luigi Gonzaga

NewYork–Presbyterian Hospital

W. Zou is an author at Northwest Behavioral Medicine specializing in disease-free survival assessment, adjuvant clinical trials, and chemotherapy.

ORCID

Publications per year

2022–2024

2

Publications

2

1O IMpower010: ctDNA status in patients (pts) with resected NSCLC who received adjuvant chemotherapy (chemo) followed by atezolizumab (atezo) or best supportive care (BSC)

Enriqueta Felip, M. Srivastava, Martin Reck et al. · Immuno-Oncology Technology · 2022 · 20 citations · Full text

, , +16

1211P IMpower010: ctDNA status and 5y DFS follow up in patients (pts) with resected NSCLC who received adjuvant chemotherapy (chemo) followed by atezolizumab (atezo) or best supportive care (BSC)

H. Wakelee, Martin Reck, Enriqueta Felip et al. · Annals of Oncology · 2024 · 11 citations · Full text

, , +8

1–2 of 2